Further deficiencies included the equal weighting given to male and female breast cancers and the inability to input bilateral breast cancer or other tumours associated with BRCA1/2 mutation, namely prostate and pancreatic cancers (Lynch et al, 1999; Tulinius et al, 2002; Liede et al, 2004). This evidence concerns the gene BRCA1 and breast cancer.